Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway

Toxicology and Applied Pharmacology

Volumn 271, Issue 1, 2013, Pages 20-29

  Wang, Zhishan ^a   Humphries, Brock ^a   Xiao, Hua ^a   Jiang, Yiguo ^b   Yang, Chengfeng ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Catenin; Angiogenesis; Arsenic transformed cells; Epithelial to mesenchymal transition (EMT); MicroRNA 200b (miR 200b); Wnt

Indexed keywords

ARSENIC; ARSENITE SODIUM; BETA CATENIN; MESSENGER RNA; MICRORNA 200B; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; VASCULOTROPIN; WNT PROTEIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BRONCHIAL EPITHELIAL CELL; BRONCHUS MUCOSA; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; INOCULATION; NONHUMAN; PROTEIN STABILITY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

Β-CATENIN; ANGIOGENESIS; ARSENIC-TRANSFORMED CELLS; EMT; EPITHELIAL-TO-MESENCHYMAL TRANSITION; EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT); HUMAN BRONCHIAL EPITHELIAL CELLS (HBECS) WITH P53 EXPRESSION STABLY KNOCKED DOWN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELL; HUVEC; IF; IMMUNOFLUORESCENCE; MICRORNA 200B; MICRORNA-200B (MIR-200B); MIR-200B; P53(LOW)HBECS; SIRNA; SMALL INTERFERING RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF; WNT;

ANIMALS; ARSENIC; BETA CATENIN; BRONCHI; CELL LINE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878745464     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.04.018     Document Type: Article

References (38)

1. Achanzar W.E., Brambila E.M., Diwan B.A., Webber M.M., Waalkes M.P. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 2002, 94:1888-1891.
2. Benbrahim-Tallaa L., Waalkes M.P. Inorganic arsenic and human prostate cancer. Environ. Health Perspect. 2008, 116:158-164.
3. Celik I., Gallicchio L., Boyd K., Lam T.K., Matanoski G., Tao X., Shiels M., Hammond E., Chen L., Robinson K.A., Caulfield L.E., Herman J.G., Guallar E., Alberg A.J. Arsenic in drinking water and lung cancer: a systematic review. Environ. Res. 2008, 108:48-55.
4. Chervona Y., Arita A., Costa M. Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 2012, 4:619-627.
5. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149:1192-1205.
6. Deraz E.M., Kudo Y., Yoshida M., Obayashi M., Tsunematsu T., Tani H., Siriwardena S.B., Keikhaee M.R., Qi G., Iizuka S., Ogawa I., Campisi G., Lo Muzio L., Abiko Y., Kikuchi A., Takata T. MMP-10/stromelysin-2 promotes invasion of head and neck cancer. PLoS One 2011, 6:e25438.
7. Fang J., Xia C., Cao Z., Zheng J.Z., Reed E., Jiang B.H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 2005, 19:342-353.
8. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
9. Gregory P.A., Bracken C.P., Bert A.G., Goodall G.J. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008, 7:3112-3118.
10. Haudek K.C., Voss P.G., Locascio L.E., Wang J.L., Patterson R.J. A mechanism for incorporation of galectin-3 into the spliceosome through its association with U1 snRNP. Biochemistry 2009, 48:7705-7712.
11. Iorio M.V., Croce C.M. MicroRNA involvement in human cancer. Carcinogenesis 2012, 33:1126-1133.
12. Jiang R., Li Y., Xu Y., Zhou Y., Pang Y., Shen L., Zhao Y., Zhang J., Zhou J., Wang X., Liu Q. EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes. Arch. Toxicol. 2012, (in press) (Oct 16. [Epub ahead of print]).
13. Kao Y.H., Yu C.L., Chang L.W., Yu H.S. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem. Res. Toxicol. 2003, 16:460-468.
14. Klemm F., Bleckmann A., Siam L., Chuang H.N., Rietkötter E., Behme D., Schulz M., Schaffrinski M., Schindler S., Trümper L., Kramer F., Beissbarth T., Stadelmann C., Binder C., Pukrop T. β-Catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis 2011, 32:434-442.
15. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
16. Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
17. Li A., Zhang C., Gao S., Chen F., Yang C., Luo R., Xiao H. TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice. Oncogene 2012, (Jun 25, [Epub ahead of print]). 10.1038/onc.2012.253.
18. Liu J., Waalkes M.P. Liver is a target of arsenic carcinogenesis. Toxicol. Sci. 2008, 105:24-32.
19. Liu L.Z., Jiang Y., Carpenter R.L., Jing Y., Peiper S.C., Jiang B.H. Role and mechanism of arsenic in regulating angiogenesis. PLoS One 2011, 6:e20858.
20. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., Westermann F., Speleman F., Vandesompele J., Weinberg R.A. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
21. Meng D., Wang X., Chang Q., Hitron A., Zhang Z., Xu M., Chen G., Luo J., Jiang B., Fang J., Shi X. Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol. Appl. Pharmacol. 2010, 244:291-299.
22. Pi J., Diwan B.A., Sun Y., Liu J., Qu W., He Y., Styblo M., Waalkes M.P. Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. Free Radic. Biol. Med. 2008, 45:651-658.
23. Rossman T.G., Klein C.B. Genetic and epigenetic effects of environmental arsenicals. Metallomics 2011, 3:1135-1141.
24. Sato M., Vaughan M.B., Girard L., Peyton M., Lee W., Shames D.S., Ramirez R.D., Sunaga N., Gazdar A.F., Shay J.W., Minna J.D. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 2006, 66:2116-2128.
25. Soucy N.V., Ihnat M.A., Kamat C.D., Hess L., Post M.J., Klei L.R., Clark C., Barchowsky A. Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol. Sci. 2003, 76:271-279.
26. Tapio S., Grosche B. Arsenic in the aetiology of cancer. Mutat. Res. 2006, 612:215-246.
27. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
28. Tokar E.J., Diwan B.A., Waalkes M.P. Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice. Toxicol. Lett. 2012, 209:179-185.
29. Vyakarnam A., Lenneman A.J., Lakkides K.M., Patterson R.J., Wang J.L. A comparative nuclear localization study of galectin-1 with other splicing components. Exp. Cell Res. 1998, 242:419-428.
30. Wang Z., Zhao Y., Smith E., Goodall G.J., Drew P.A., Brabletz T., Yang C. Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol. Sci. 2011, 121:110-122.
31. Wang L., Son Y.O., Ding S., Wang X., Hitron J.A., Budhraja A., Lee J.C., Lin Q., Poyil P., Zhang Z., Luo J., Shi X. Ethanol enhances tumor angiogenesis in vitro induced by low-dose arsenic in colon cancer cells through hypoxia-inducible factor 1 alpha pathway. Toxicol. Sci. 2012, 130:269-280.
32. Wang Z., Yang J., Fisher T., Xiao H., Jiang Y., Yang C. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ. Health Perspect. 2012, 120:92-97.
33. Weis S.M., Cheresh D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 2011, 17:1359-1370.
34. Xu Y., Li Y., Pang Y., Ling M., Shen L., Yang X., Zhang J., Zhou J., Wang X., Liu Q. EMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One 2012, 7:e37765.
35. Yang C. Letter to the editor: response to concerns about arsenic-induced epithelial to mesenchymal transition and malignant transformation of human bronchial epithelial cells. Toxicol. Sci. 2011, 122:607-609.
36. Zerlin M., Julius M.A., Kitajewski J. Wnt/Frizzled signaling in angiogenesis. Angiogenesis 2008, 11:63-69.
37. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10907-10912.
38. Zhao Y., Tan Y.S., Haslam S.Z., Yang C. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice. Toxicol. Sci. 2010, 115:214-224.